Clinical Trial

A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluation the long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-05-29.
Status change: Not Yet Recruiting → Recruiting 2025-12-11
Trial Details
NCT Number NCT06441812
Lead Sponsor Guangdong Hengrui Pharmaceutical Co., Ltd
Conditions Eosinophilic Asthma Patients
Enrollment 200 participants
Start Date 2024-07-19
Primary Completion 2028-09 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2025-12-18